NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/28/2023
Back to search
Official data from USPTO
NOVODIAG
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NOVODIAG
ST13
US500000087780305Class
1, 5, 9, 10
Filing
87780305
Registration
7227124
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
68
Latest update
11/28/2023
Trademark type
Word
Nice classes
1, 5, 9, 10
Filing date
02/01/2018
Registration date
11/28/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/28/2023
Last transaction
11/28/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
99
Owner location
ESPOO, FI
Examiner
PEISECKI, MARK
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Mobidiag Oy
Representatives
Charles F. Reidelbach, Jr., Esq. HIGGS FLETCHER & MACK LLP
Technical classification
Nice Classes
Class 1Class 5Class 9Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Reagents for scientific and research use; Reagentsother than for medical usefor sale in kit form and comprising of reagents for detecting nucleic acids or other biological markers; Reagents for in-vitro useother than for medical purposes; Diagnostic preparations and reagents for scientific and research usefor in- vitro useother than medical use; chemical tests for scientific and research use for detecting nucleic acids or other biological markers; chemical testsother than for medical use for sale in kit form for detecting nucleic acids or other biological markers; chemical tests for in-vitro useother than for medical usefor detecting nucleic acids or other biological markers
Class 5
Pharmaceutical and veterinary preparations for detecting nucleic acids or other biological markers from animals or their microbes; sanitary preparations for medical purposes; Medical diagnostic reagents and assays that test for the presence of pathogens and infection; medical diagnostic kits comprised of medical diagnostic reagents and assays that test for the presence of pathogens and infection; medical diagnostic reagents and assays that test body fluids for microorganisms; medical diagnostic kits comprised of medical diagnostic reagents and assays that test body fluids for microorganisms; medical diagnostic reagents for the extractionamplificationpurification of nucleic acids; clinical medical reagents and assays for the extraction amplificationpurification of nucleic acids
Class 9
Computer hardware and software for scientificindustrial and medical analysis and research purposescomputer hardware and recorded software for use in in-vitro diagnostics and for detecting nucleic acids or other biological markersin particular for the diagnosis of medical conditions in humans and animals; laboratory robots
Class 10
Surgicalmedicaldental and veterinary equipment and instruments for clinical diagnosis purposeslaboratory equipment for use in in-vitro diagnostics or for detecting nucleic acids or other biological markersin particular for detecting infectious diseasesfor medical purposes
Publications
History of USPTO decisions and trademark events.
68 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/28/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/12/2023
PUBO
PUBLISHED FOR OPPOSITION
09/12/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/23/2023
CORV
REVIEW OF CORRESPONDENCE COMPLETE
07/07/2023
OTHE
CASE RETURNED TO EXAMINATION
07/07/2023
IUCN
NOTICE OF ALLOWANCE CANCELLED
07/07/2023
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
07/04/2023
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
07/04/2023
APET
ASSIGNED TO PETITION STAFF
06/30/2023
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
06/12/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/08/2023
EX5G
SOU EXTENSION 5 GRANTED
02/07/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/06/2023
EXT5
SOU EXTENSION 5 FILED
01/19/2023
EEXT
SOU TEAS EXTENSION RECEIVED
01/19/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/16/2022
EX4G
SOU EXTENSION 4 GRANTED
07/14/2022
EXT4
SOU EXTENSION 4 FILED
07/14/2022
EEXT
SOU TEAS EXTENSION RECEIVED
07/14/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/11/2022
EX3G
SOU EXTENSION 3 GRANTED
02/09/2022
EXT3
SOU EXTENSION 3 FILED
02/09/2022
EEXT
SOU TEAS EXTENSION RECEIVED
02/09/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/13/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
10/13/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/13/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/13/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/21/2021
EX2G
SOU EXTENSION 2 GRANTED
07/19/2021
EXT2
SOU EXTENSION 2 FILED
07/19/2021
EEXT
SOU TEAS EXTENSION RECEIVED
07/19/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/11/2021
EX1G
SOU EXTENSION 1 GRANTED
02/09/2021
EXT1
SOU EXTENSION 1 FILED
02/09/2021
EEXT
SOU TEAS EXTENSION RECEIVED
02/09/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/18/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/23/2020
PUBO
PUBLISHED FOR OPPOSITION
06/23/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/03/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/15/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
05/15/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/15/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
05/15/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/15/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/08/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/08/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/08/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/08/2019
GNRT
NON-FINAL ACTION E-MAILED
11/08/2019
CNRT
NON-FINAL ACTION WRITTEN
11/08/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/16/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/15/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/15/2019
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
02/19/2019
GPRA
PRIORITY ACTION E-MAILED
02/19/2019
CPRA
PRIORITY ACTION WRITTEN
02/19/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/20/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/20/2018
ALIE
ASSIGNED TO LIE
11/19/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/06/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/08/2018
GNRT
NON-FINAL ACTION E-MAILED
05/08/2018
CNRT
NON-FINAL ACTION WRITTEN
05/08/2018
DOCK
ASSIGNED TO EXAMINER
05/02/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/11/2018
NWAP
NEW APPLICATION ENTERED
02/05/2018
Continuous trademark protection
Get notified about every new filing that threatens NOVODIAG or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.